Unique ID issued by UMIN | UMIN000051709 |
---|---|
Receipt number | R000059016 |
Scientific Title | Pilot study on pharmacokinetics of tea ingredients |
Date of disclosure of the study information | 2023/07/25 |
Last modified on | 2023/07/25 14:35:20 |
Pilot study on pharmacokinetics of tea ingredients
Pharmacokinetic study of tea ingredients
Pilot study on pharmacokinetics of tea ingredients
Pharmacokinetic study of tea-derived ingredients
Japan |
healthy adults
Adult |
Others
NO
Examine how much the polyphenol component of ingested tea is transferred to the blood and saliva.
Pharmacokinetics
Blood concentration and saliva concentration of tea polyphenols
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
After obtaining consent from the subjects, the subjects were randomly selected to ingest one of tea candy 1, tea candy 2, or placebo candy, and blood and saliva were collected immediately after, 1 hour, and 2 hours after ingestion (first day of the test).
At least 24 hours later, the subjects were asked to ingest another type of candy, and blood and saliva were collected immediately, 1 hour, and 2 hours after ingestion (second day of the test).
After another 24 hours or more, the subjects were asked to ingest another type of candy, and blood and saliva were collected immediately, 1 hour, and 2 hours after ingestion (3rd day of the test).
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1.Healthy adult men and women with no subjective symptoms
2.Those who can obtain written consent from the person to participate in the research voluntarily
3.Age between 20 and 65 at the time of obtaining consent (regardless of gender)
1.Subjects with serious liver disorder, cardiovascular disorder, respiratory disorder, endocrine disorder, metabolic disorder
2.Subjects who may have an allergic reaction to tea or test food
3.Subjects who are pregnant, breastfeeding, or intend to become pregnant during the study period
4.Irregular menstrual cycle
5. Persons with extremely irregular eating habits, shift workers, late-night workers
6.Subjects who have collected more than 200 mL of blood within 1 month or more than 400 mL within 3 months before the start of this study (blood donation, etc.)
7.Subjects who regularly use pharmaceuticals (including herbal medicines) and supplements
8.Those who cannot agree with the purpose of the explanation of the test conducted in advance.
9.In addition, those who are judged to be inappropriate for this study by the study supervisor
10
1st name | Osam |
Middle name | |
Last name | Mazda |
kyoto prefectural university of medicine
Department of Immunology
602-8566
Kyoto-shi, Kamigyo-ku Kajii-cho, Kawaramachi-Hirokoji 465, JAPAN
0752515329
mazda@koto.kpu-m.ac.jp
1st name | Eri |
Middle name | |
Last name | Watanabe |
kyoto prefectural university of medicine
Department of Immunology
6028566
Kyoto-shi, Kamigyo-ku Kajii-cho, Kawaramachi-Hirokoji 465, JAPAN
0752515329
e-w@koto.kpu-m.ac.jp
kyoto prefectural university of medicine
ITO EN, LTD.
Profit organization
Japan
Kyoto Prefectural University of Medicine Medical Ethics Review Committee
Kyoto-shi, Kamigyo-ku Kajii-cho, Kawaramachi-Hirokoji 465, JAPAN
075-251-5337
rinri@koto.kpu-m.ac.jp
NO
2023 | Year | 07 | Month | 25 | Day |
Unpublished
Preinitiation
2023 | Year | 07 | Month | 25 | Day |
2023 | Year | 09 | Month | 01 | Day |
2027 | Year | 03 | Month | 31 | Day |
2023 | Year | 07 | Month | 25 | Day |
2023 | Year | 07 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059016